Metformin XR 500 mg

DRUG2 trials

Sponsors

AstraZeneca, Myopharm Limited

Conditions

Type 2 Diabetes (T2DM)Type 2 Diabetes Mellitus(T2DM)

Phase 1

A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration

CompletedNCT01755494

AstraZenecaType 2 Diabetes Mellitus(T2DM)

Start: 2013-02-28End: 2013-04-30Updated: 2013-12-13

Phase 2

TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT

Not yet recruitingNCT07139405

Myopharm LimitedType 2 Diabetes (T2DM)

Start: 2026-02-28End: 2028-06-30Target: 90Updated: 2025-08-24